Patent Oppositions in microorganisms and genetic engineering industry

Explore the competitive field of microorganisms and genetic engineering where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in microorganisms and genetic engineering technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the microorganisms and genetic engineering industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the microorganisms and genetic engineering industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 5, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Lactose Reduced Dairy PowderDSM ASSETSNov 4, 2026INTERNATIONAL N&H DENMARK APS
Composition Containing EnzymeUNILEVERNov 2, 2026HENKEL
Mucosal-Associated Invariant T (Mait) Cells Expressing Chimeric Antigen ReceptorsINSTITUT CURIEOct 28, 2026GOODWIN PROCTER UK
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 21, 2026STORZ
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 20, 2026GRUNECKER PATENT UND RECHTSANWALTE PARTG MBB
Method For Producing Modified Oligonucleotide Including Complementary SequenceAJINOMOTOOct 19, 2026JAMES POOLE
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHAOct 7, 2026PAGE
Methods And Compositions For Transducing And Expanding Lymphocytes And Regulating The Activity ThereofF1 ONCOLOGYOct 7, 2026PATENT BOUTIQUE
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE UNITED STATES OF AMERICASep 30, 2026KELTIE
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN

To stay ahead in the competitive microorganisms and genetic engineering industry, companies are constantly innovating. Here are the top patents facing oppositions in the microorganisms and genetic engineering industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 5, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Sep 20, 2017Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
Nov 27, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNA9
Feb 11, 2015Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence ManipulationTHE BROAD INSTITUTE9
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
Sep 2, 2015Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence ManipulationMASSACHUSETTS INSTITUTE OF TECHNOLOGY8
Jan 10, 2018Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHON8